Amarin Corp Plcuk (AMRN) Long-Term Debt Issuances (2012 - 2017)
Amarin Corp Plcuk (AMRN) reported Long-Term Debt Issuances of $30.0 million for Q1 2017, up 26.05% quarter-over-quarter from $23.8 million in Q1 2014.
Amarin Corp Plcuk (AMRN) Long-Term Debt Issuances (2012 - 2017) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 3 years of Long-Term Debt Issuances data on file, last reported at $30.0 million in Q1 2017.
- Long-Term Debt Issuances for Q1 2017 came in at $30.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2017 was $53.8 million (changed N/A YoY), and the FY2015 annual result was $27.5 million, changed N/A from the prior year.
- Long-Term Debt Issuances rose to $30.0 million in Q1 2017 per AMRN's latest filing, from $23.8 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $30.0 million in Q1 2017 and troughed at $23.8 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 7.99 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 3.96 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | - |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 30.00 Mn |
| Mar 31, 2017 | 30.00 Mn |
| Mar 31, 2014 | 23.80 Mn |
| Mar 31, 2014 | 23.80 Mn |
| Mar 31, 2012 | 144.32 Mn |
| Mar 31, 2012 | 144.32 Mn |